ATLANTA--(BUSINESS WIRE)--Curant Health, a rare disease specialty pharmacy that improves health outcomes for rare and complex care patients, has been chosen by IntraBio as the exclusive specialty pharmacy for AQNEURSA™ (levacetylleucine). This groundbreaking therapy is the first FDA-approved stand-alone treatment for Niemann-Pick Disease Type C (NPC), a rare genetic disorder. AQNEURSA™ represents a significant advancement in the […]